Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Open in API
Filings indexed 490 across all filing types
Latest filing 2025-05-23 Regulatory Filings
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the scheduling of a Board of Directors meeting to consider and approve the audited financial results for the quarter and year ended 31st March 2025. It references compliance with SEBI regulations and insider trading rules, and mentions the closure and reopening of the trading window around the announcement of financial results. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of an upcoming event related to financial reporting, not the report itself. The document length is short (2336 characters), and it serves as an intimation under regulatory obligations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and notification documents that do not contain the actual report or detailed financial data.
2025-05-23 English
General Updates
Legal Proceedings Report Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding a legal proceeding initiated against the company under the Insolvency and Bankruptcy Code, 2016. It references a specific petition number filed at the National Company Law Tribunal and provides details about the claim and the company's response. The document is short (1956 characters) and serves as an update or announcement about legal proceedings rather than a detailed report or financial statement. It does not contain financial data, audit information, or management discussion. Therefore, it fits the category of Legal Proceedings Report (LTR).
2025-05-16 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding a change in contact details of the company's Registrar and Share Transfer Agent (RTA). It does not contain financial data, management discussion, voting results, or any report content. The document is short (1479 characters) and serves as an announcement of administrative changes rather than a financial or regulatory report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-04-19 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-04-11 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March 2025. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialisation of securities and related compliance. The document is short (3177 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits the category of a Regulatory Filing (RNS), which covers officer certifications and compliance confirmations that do not qualify as full reports.
2025-04-11 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the closure of the trading window for insiders due to upcoming financial results disclosure. It references regulatory compliance with insider trading regulations and the timing of the trading restriction period around the declaration of audited financial statements for the quarter and financial year ended March 31, 2025. The document does not contain any financial data, results, or detailed report content itself, but rather is an announcement about the trading window closure related to the upcoming financial results. The document length is short (1585 characters), and it serves as an intimation or regulatory announcement rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-03-26 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.